BBC vs. XLVI
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) are both exchange-traded funds - BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while XLVI is a Derivative Income fund actively managed by State Street. BBC is passively managed, while XLVI is actively managed. At a 0.39 correlation, their price movements are largely independent. BBC charges 0.79%/yr vs 0.35%/yr for XLVI.
Performance
BBC vs. XLVI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 8.17% return, which is significantly higher than XLVI's -1.33% return.
BBC
- 1D
- -4.90%
- 1M
- -4.81%
- YTD
- 8.17%
- 6M
- 20.12%
- 1Y
- 123.11%
- 3Y*
- 19.82%
- 5Y*
- -2.05%
- 10Y*
- 7.60%
XLVI
- 1D
- -0.73%
- 1M
- 1.42%
- YTD
- -1.33%
- 6M
- 0.46%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BBC vs. XLVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.17% | 77.19% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | -1.33% | 12.79% |
Correlation
The correlation between BBC and XLVI is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jul 31, 2025 | 0.39 |
BBC vs. XLVI - Sectors Allocation Comparison
Sectors
BBC
XLVI
Healthcare
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
BBC
XLVI
-
Basic Materials
BBC
-
XLVI
-
Communication Services
BBC
-
XLVI
-
Consumer Cyclical
BBC
-
XLVI
-
Consumer Defensive
BBC
-
XLVI
-
Energy
BBC
-
XLVI
-
Financial Services
BBC
-
XLVI
Industrials
BBC
-
XLVI
-
Real Estate
BBC
-
XLVI
-
Technology
BBC
-
XLVI
-
Utilities
BBC
-
XLVI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. XLVI — Risk / Return Rank
BBC
XLVI
BBC vs. XLVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBC | XLVI | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.49 | — | — |
Sortino ratioReturn per unit of downside risk | 4.11 | — | — |
Omega ratioGain probability vs. loss probability | 1.48 | — | — |
Calmar ratioReturn relative to maximum drawdown | 8.82 | — | — |
Martin ratioReturn relative to average drawdown | 28.55 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBC | XLVI | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.49 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | 1.25 | -1.13 |
Drawdowns
BBC vs. XLVI - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than XLVI's maximum drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for BBC and XLVI.
Loading charts...
Drawdown Indicators
| BBC | XLVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -8.14% | -68.71% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | — | — |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -72.44% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | — | — |
Current DrawdownCurrent decline from peak | -30.57% | -4.66% | -25.91% |
Average DrawdownAverage peak-to-trough decline | -37.14% | -1.94% | -35.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.66% | — | — |
Volatility
BBC vs. XLVI - Volatility Comparison
Loading charts...
Volatility by Period
| BBC | XLVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.21% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 26.65% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 35.74% | 10.94% | +24.80% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.31% | 10.94% | +28.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.75% | 10.94% | +26.81% |
BBC vs. XLVI - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than XLVI's 0.35% expense ratio.
Dividends
BBC vs. XLVI - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.57%, less than XLVI's 11.61% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.57% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 11.61% | 5.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BBC and XLVI have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XLVI is cheaper with a 0.35% expense ratio, compared with 0.79% for BBC.
XLVI has the higher dividend yield at 11.61%, compared with 1.57% for BBC.
BBC is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: Virtus Investment Partners and State Street. Their fees differ too: 0.79% for BBC and 0.35% for XLVI.
Find the right allocation for BBC and XLVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer